• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global RNAi drug delivery market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global rnai drug delivery market 2017 – 2021 ($ billion)
o 4.2 Technology Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Technology Segment 2017 – 2021 ($ billion)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Technology
o 6.1 Market segments
o Exhibit 30: Chart on Technology – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Technology – Market share 2022-2027 (%)
o 6.2 Comparison by Technology
o Exhibit 32: Chart on Comparison by Technology
o Exhibit 33: Data Table on Comparison by Technology
o 6.3 Nanoparticle drug delivery – Market size and forecast 2022-2027
o Exhibit 34: Chart on Nanoparticle drug delivery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Nanoparticle drug delivery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Nanoparticle drug delivery – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Nanoparticle drug delivery – Year-over-year growth 2022-2027 (%)
o 6.4 Pulmonary drug delivery – Market size and forecast 2022-2027
o Exhibit 38: Chart on Pulmonary drug delivery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Pulmonary drug delivery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Pulmonary drug delivery – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Pulmonary drug delivery – Year-over-year growth 2022-2027 (%)
o 6.5 Nucleic acid drug delivery – Market size and forecast 2022-2027
o Exhibit 42: Chart on Nucleic acid drug delivery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Nucleic acid drug delivery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Nucleic acid drug delivery – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Nucleic acid drug delivery – Year-over-year growth 2022-2027 (%)
o 6.6 Aptamer drug delivery – Market size and forecast 2022-2027
o Exhibit 46: Chart on Aptamer drug delivery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Aptamer drug delivery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Aptamer drug delivery – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Aptamer drug delivery – Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Technology
o Exhibit 50: Market opportunity by Technology ($ billion)
o Exhibit 51: Data Table on Market opportunity by Technology ($ billion)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 52: Chart on Application – Market share 2022-2027 (%)
o Exhibit 53: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 54: Chart on Comparison by Application
o Exhibit 55: Data Table on Comparison by Application
o 7.3 Infectious diseases – Market size and forecast 2022-2027
o Exhibit 56: Chart on Infectious diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Infectious diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Infectious diseases – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Infectious diseases – Year-over-year growth 2022-2027 (%)
o 7.4 Oncology – Market size and forecast 2022-2027
o Exhibit 60: Chart on Oncology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Oncology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Oncology – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
o 7.5 Cardiology – Market size and forecast 2022-2027
o Exhibit 64: Chart on Cardiology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Cardiology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Cardiology – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Cardiology – Year-over-year growth 2022-2027 (%)
o 7.6 Neurology – Market size and forecast 2022-2027
o Exhibit 68: Chart on Neurology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Neurology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Neurology – Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Neurology – Year-over-year growth 2022-2027 (%)
o 7.7 Others – Market size and forecast 2022-2027
o Exhibit 72: Chart on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Application
o Exhibit 76: Market opportunity by Application ($ billion)
o Exhibit 77: Data Table on Market opportunity by Application ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 81: Chart on Geographic comparison
o Exhibit 82: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 83: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 87: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 91: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 95: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 99: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 103: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 111: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 115: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 116: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 117: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 121: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 123: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 124: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 125: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 126: Matrix on vendor position and classification
o 12.3 Alnylam Pharmaceuticals Inc.
o Exhibit 127: Alnylam Pharmaceuticals Inc. – Overview
o Exhibit 128: Alnylam Pharmaceuticals Inc. – Product / Service
o Exhibit 129: Alnylam Pharmaceuticals Inc. – Key news
o Exhibit 130: Alnylam Pharmaceuticals Inc. – Key offerings
o 12.4 Arbutus Biopharma Corp.
o Exhibit 131: Arbutus Biopharma Corp. – Overview
o Exhibit 132: Arbutus Biopharma Corp. – Product / Service
o Exhibit 133: Arbutus Biopharma Corp. – Key offerings
o 12.5 Arrowhead Pharmaceuticals Inc.
o Exhibit 134: Arrowhead Pharmaceuticals Inc. – Overview
o Exhibit 135: Arrowhead Pharmaceuticals Inc. – Business segments
o Exhibit 136: Arrowhead Pharmaceuticals Inc. – Key offerings
o Exhibit 137: Arrowhead Pharmaceuticals Inc. – Segment focus
o 12.6 Bayer AG
o Exhibit 138: Bayer AG – Overview
o Exhibit 139: Bayer AG – Business segments
o Exhibit 140: Bayer AG – Key news
o Exhibit 141: Bayer AG – Key offerings
o Exhibit 142: Bayer AG – Segment focus
o 12.7 BioNTech SE
o Exhibit 143: BioNTech SE – Overview
o Exhibit 144: BioNTech SE – Product / Service
o Exhibit 145: BioNTech SE – Key offerings
o 12.8 Bristol Myers Squibb Co.
o Exhibit 146: Bristol Myers Squibb Co. – Overview
o Exhibit 147: Bristol Myers Squibb Co. – Product / Service
o Exhibit 148: Bristol Myers Squibb Co. – Key news
o Exhibit 149: Bristol Myers Squibb Co. – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 150: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 151: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 152: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 153: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 154: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Novartis AG
o Exhibit 155: Novartis AG – Overview
o Exhibit 156: Novartis AG – Business segments
o Exhibit 157: Novartis AG – Key offerings
o Exhibit 158: Novartis AG – Segment focus
o 12.11 Novo Nordisk AS
o Exhibit 159: Novo Nordisk AS – Overview
o Exhibit 160: Novo Nordisk AS – Business segments
o Exhibit 161: Novo Nordisk AS – Key offerings
o Exhibit 162: Novo Nordisk AS – Segment focus
o 12.12 Phio Pharmaceuticals
o Exhibit 163: Phio Pharmaceuticals – Overview
o Exhibit 164: Phio Pharmaceuticals – Product / Service
o Exhibit 165: Phio Pharmaceuticals – Key offerings
o 12.13 Sanofi
o Exhibit 166: Sanofi – Overview
o Exhibit 167: Sanofi – Business segments
o Exhibit 168: Sanofi – Key news
o Exhibit 169: Sanofi – Key offerings
o Exhibit 170: Sanofi – Segment focus
o 12.14 Silence Therapeutics plc
o Exhibit 171: Silence Therapeutics plc – Overview
o Exhibit 172: Silence Therapeutics plc – Product / Service
o Exhibit 173: Silence Therapeutics plc – Key offerings
o 12.15 Sirnaomics Inc.
o Exhibit 174: Sirnaomics Inc. – Overview
o Exhibit 175: Sirnaomics Inc. – Product / Service
o Exhibit 176: Sirnaomics Inc. – Key offerings
o 12.16 Sylentis S.A.
o Exhibit 177: Sylentis S.A. – Overview
o Exhibit 178: Sylentis S.A. – Product / Service
o Exhibit 179: Sylentis S.A. – Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 180: Thermo Fisher Scientific Inc. – Overview
o Exhibit 181: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 182: Thermo Fisher Scientific Inc. – Key news
o Exhibit 183: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 184: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 185: Inclusions checklist
o Exhibit 186: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 187: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 188: Research methodology
o Exhibit 189: Validation techniques employed for market sizing
o Exhibit 190: Information sources
o 13.5 List of abbreviations
o Exhibit 191: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Technology
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global rnai drug delivery market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Technology Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Technology – Market share 2022-2027 (%)
Exhibits31: Data Table on Technology – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Technology
Exhibits33: Data Table on Comparison by Technology
Exhibits34: Chart on Nanoparticle drug delivery – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Nanoparticle drug delivery – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Nanoparticle drug delivery – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Nanoparticle drug delivery – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Pulmonary drug delivery – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Pulmonary drug delivery – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Pulmonary drug delivery – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Pulmonary drug delivery – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Nucleic acid drug delivery – Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Nucleic acid drug delivery – Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Nucleic acid drug delivery – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Nucleic acid drug delivery – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Aptamer drug delivery – Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Aptamer drug delivery – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Aptamer drug delivery – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Aptamer drug delivery – Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Technology ($ billion)
Exhibits51: Data Table on Market opportunity by Technology ($ billion)
Exhibits52: Chart on Application – Market share 2022-2027 (%)
Exhibits53: Data Table on Application – Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Application
Exhibits55: Data Table on Comparison by Application
Exhibits56: Chart on Infectious diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Infectious diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Infectious diseases – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Infectious diseases – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Oncology – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Oncology – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Cardiology – Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Cardiology – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Cardiology – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Cardiology – Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Neurology – Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Neurology – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Neurology – Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Neurology – Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits76: Market opportunity by Application ($ billion)
Exhibits77: Data Table on Market opportunity by Application ($ billion)
Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits81: Chart on Geographic comparison
Exhibits82: Data Table on Geographic comparison
Exhibits83: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits116: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits117: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits119: Market opportunity By Geographical Landscape ($ billion)
Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits121: Impact of drivers and challenges in 2022 and 2027
Exhibits122: Overview on Criticality of inputs and Factors of differentiation
Exhibits123: Overview on factors of disruption
Exhibits124: Impact of key risks on business
Exhibits125: Vendors covered
Exhibits126: Matrix on vendor position and classification
Exhibits127: Alnylam Pharmaceuticals Inc. – Overview
Exhibits128: Alnylam Pharmaceuticals Inc. – Product / Service
Exhibits129: Alnylam Pharmaceuticals Inc. – Key news
Exhibits130: Alnylam Pharmaceuticals Inc. – Key offerings
Exhibits131: Arbutus Biopharma Corp. – Overview
Exhibits132: Arbutus Biopharma Corp. – Product / Service
Exhibits133: Arbutus Biopharma Corp. – Key offerings
Exhibits134: Arrowhead Pharmaceuticals Inc. – Overview
Exhibits135: Arrowhead Pharmaceuticals Inc. – Business segments
Exhibits136: Arrowhead Pharmaceuticals Inc. – Key offerings
Exhibits137: Arrowhead Pharmaceuticals Inc. – Segment focus
Exhibits138: Bayer AG – Overview
Exhibits139: Bayer AG – Business segments
Exhibits140: Bayer AG – Key news
Exhibits141: Bayer AG – Key offerings
Exhibits142: Bayer AG – Segment focus
Exhibits143: BioNTech SE – Overview
Exhibits144: BioNTech SE – Product / Service
Exhibits145: BioNTech SE – Key offerings
Exhibits146: Bristol Myers Squibb Co. – Overview
Exhibits147: Bristol Myers Squibb Co. – Product / Service
Exhibits148: Bristol Myers Squibb Co. – Key news
Exhibits149: Bristol Myers Squibb Co. – Key offerings
Exhibits150: F. Hoffmann La Roche Ltd. – Overview
Exhibits151: F. Hoffmann La Roche Ltd. – Business segments
Exhibits152: F. Hoffmann La Roche Ltd. – Key news
Exhibits153: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits155: Novartis AG – Overview
Exhibits156: Novartis AG – Business segments
Exhibits157: Novartis AG – Key offerings
Exhibits158: Novartis AG – Segment focus
Exhibits159: Novo Nordisk AS – Overview
Exhibits160: Novo Nordisk AS – Business segments
Exhibits161: Novo Nordisk AS – Key offerings
Exhibits162: Novo Nordisk AS – Segment focus
Exhibits163: Phio Pharmaceuticals – Overview
Exhibits164: Phio Pharmaceuticals – Product / Service
Exhibits165: Phio Pharmaceuticals – Key offerings
Exhibits166: Sanofi – Overview
Exhibits167: Sanofi – Business segments
Exhibits168: Sanofi – Key news
Exhibits169: Sanofi – Key offerings
Exhibits170: Sanofi – Segment focus
Exhibits171: Silence Therapeutics plc – Overview
Exhibits172: Silence Therapeutics plc – Product / Service
Exhibits173: Silence Therapeutics plc – Key offerings
Exhibits174: Sirnaomics Inc. – Overview
Exhibits175: Sirnaomics Inc. – Product / Service
Exhibits176: Sirnaomics Inc. – Key offerings
Exhibits177: Sylentis S.A. – Overview
Exhibits178: Sylentis S.A. – Product / Service
Exhibits179: Sylentis S.A. – Key offerings
Exhibits180: Thermo Fisher Scientific Inc. – Overview
Exhibits181: Thermo Fisher Scientific Inc. – Business segments
Exhibits182: Thermo Fisher Scientific Inc. – Key news
Exhibits183: Thermo Fisher Scientific Inc. – Key offerings
Exhibits184: Thermo Fisher Scientific Inc. – Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations